Loading…
Based on limited metadata, Bimeda, Inc. received an FDA Warning Letter on May 24, 2018, regarding animal and veterinary products. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be detailed from the available information. The warning falls under FDA's regulatory oversight of veterinary pharmaceuticals or related animal health products. Additional documentation would be needed to identify the specific compliance issues cited.